*2.6. Treatment of VEGF to Cervical Cancer Cell Lines and HUVEC*

Cells (2 <sup>×</sup> <sup>10</sup><sup>5</sup> /well) were plated in a 6-well plate and treated with TAO in the growth media as indicated for 48 h. Human vascular endothelial growth factor (VEGF165, H9166) was purchased from Peprotech (Rocky Hill, NJ, USA) and was dissolved in 1X PBS containing 0.1% bovine serum albumin (BSA, A-3294, Sigma-Aldrich, St. Louis, MO, USA) to make a 100 µg/mL solution. VEGF was introduced into the growth media containing TAO overnight before lysis of the cells.
